Addex Therapeutics Ltd
ADXN
$9.44
$0.525.83%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -4.78M | 9.46M | 7.57M | 5.72M | 4.52M |
| Total Depreciation and Amortization | 91.40K | 215.70K | 216.70K | 192.90K | 134.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.90M | -11.90M | -12.52M | -12.60M | -13.12M |
| Change in Net Operating Assets | 632.10K | -1.98M | -1.32M | -28.00K | -351.40K |
| Cash from Operations | -1.15M | -4.20M | -6.05M | -6.72M | -8.81M |
| Capital Expenditure | -1.50K | -1.50K | -1.50K | -2.90K | -2.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.40K | 5.14M | 5.14M | 5.16M | 5.16M |
| Cash from Investing | -24.90K | 5.14M | 5.14M | 5.15M | 5.16M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -5.80K | -8.80K | -73.70K | -141.00K | -210.90K |
| Issuance of Common Stock | 4.10K | 4.10K | 240.60K | 255.70K | 253.50K |
| Repurchase of Common Stock | 0.00 | -22.80K | -27.30K | -30.60K | -51.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 97.50K | 65.90K | -34.60K | -35.80K | -131.80K |
| Cash from Financing | 106.40K | 42.90K | 122.10K | 58.20K | -155.10K |
| Foreign Exchange rate Adjustments | -17.80K | -16.00K | 113.40K | -157.70K | -88.50K |
| Miscellaneous Cash Flow Adjustments | -- | 338.20K | -11.60K | -11.60K | -11.60K |
| Net Change in Cash | -1.09M | 1.30M | -686.30K | -1.68M | -3.91M |